Search results for: Patricia Cubi-Molla
Filter search results
Opportunity Costs of New Health Care Technologies: A Research Agenda
8 August 2018
…Karlsberg Schaffer, S., Cubi-Molla, P., Devlin, N. and Towse, A. 2016. Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. OHE Consulting Report. RePEc Danzon, P.M., Drummond, M.F.,…
Student Mental Health Research Network (SMaRteN): First Funding Call and Sandpit
26 February 2019
…from NatCen. To find out more about the funding call, click here. To register for the webinar, click here. For more information about SMaRteN, contact Chris Sampson. Cubí-Mollá, P., Shah,…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…2018. Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research. OHE Research Paper. RePEc. Karlsberg Schaffer, S., Cubi-Molla, P., Devlin,…
What Outcomes are Important in Student Mental Health and Wellbeing?
2 May 2019
…website to join the network. For more information about SMaRteN, contact Chris Sampson. Cubí-Mollá, P., Shah, K., Garside, J., Herdman, M. and Devlin, N., 2018. A Note on the Relationship…
Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds
3 March 2020
…system, and whether society is willing to trade off health gains for other benefits valued by patients and society. Cubi-Molla, P., Errea, M., Zhang, K. and Garau, M., 2020. Are…
OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare
15 June 2020
…the UK. OHE Research Paper. Available at https://www.ohe.org/publications/case-risperidone-assessing-life-cycle-value-second-generation-antipsychotics-sweden-and Cubi-Molla, P., Errea, M., Zhang, K. and Garau, M., 2020. Are cost-effectiveness thresholds fit for purpose for real-world decision making? OHE Consulting…
Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains
10 March 2021
…across clinical areas of primary care. The article was published on 5 August 2021. It can be accessed at this link and may be cited as Neri, M., Cubi-Molla, P….
OHE Conference on Drug Development in 2022: Update
18 July 2012
…Innovations, University of Oxford Professor Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) Professor Patricia Danzon, Celia Moh Professor, Professor of Health Care Management,…
European Medicines Pricing and Reimbursement: Now and the Future
1 January 2007
…Pricing and reimbursement policies in Spain: current and future trends; Overview Contributors: Claude Le Pen, J-Mattias von der Schulenburg, Martina Garau, Adrian Towse, Livio Garattini, Joan Costa-i-Font, Patricia Danzon 2007…